Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Fairlie

Showing results (141-150 of 326) with videos related to

Pageof 33
Sort By:
Chembiochem : a European Journal of Chemical Biology|September 5, 2015
Flexibility versus Rigidity for Orally Bioavailable Cyclic HexapeptidesDaniel S Nielsen, Rink-Jan Lohman, Huy N Hoang, et al.
The Journal of General Virology|June 7, 2013
An interaction between the methyltransferase and RNA dependent RNA polymerase domains of the West Nile virus NS5 proteinCindy S E Tan, Jody M Hobson-Peters, Martin J Stoermer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2012
An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in ratsRink-Jan Lohman, Adam J Cotterell, Grant D Barry, et al.
Journal of Chemical Information and Modeling|May 23, 2015
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist DiscoverySamuel R Perry, Weijun Xu, Anna Wirija, et al.
Journal of Medicinal Chemistry|December 22, 2006
Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acidPia Kahnberg, Andrew J Lucke, Matthew P Glenn, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
A refined agonist pharmacophore for protease activated receptor 2Grant D Barry, Jacky Y Suen, Heng Boon Low, et al.
The FEBS Journal|March 18, 2022
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and diseaseYizhuo Wang, Rishika Abrol, Jeffrey Y W Mak, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2017
Quinazolinone derivatives as inhibitors of homologous recombinase RAD51Ambber Ward, Lilong Dong, Jonathan M Harris, et al.
British Journal of Pharmacology|September 3, 2024
A novel inhibitor of class IIa histone deacetylases attenuates collagen-induced arthritisEunice K Poon, Ligong Liu, Kai-Chen Wu, et al.
Glia|September 19, 2017
Protease activated receptor 2 controls myelin development, resiliency and repairHyesook Yoon, Maja Radulovic, Grant Walters, et al.
Pageof 33

Showing results (141-150 of 326) with videos related to

Sort By:
Pageof 33
Chembiochem : a European Journal of Chemical Biology|September 5, 2015
Flexibility versus Rigidity for Orally Bioavailable Cyclic HexapeptidesDaniel S Nielsen, Rink-Jan Lohman, Huy N Hoang, et al.
The Journal of General Virology|June 7, 2013
An interaction between the methyltransferase and RNA dependent RNA polymerase domains of the West Nile virus NS5 proteinCindy S E Tan, Jody M Hobson-Peters, Martin J Stoermer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2012
An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in ratsRink-Jan Lohman, Adam J Cotterell, Grant D Barry, et al.
Journal of Chemical Information and Modeling|May 23, 2015
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist DiscoverySamuel R Perry, Weijun Xu, Anna Wirija, et al.
Journal of Medicinal Chemistry|December 22, 2006
Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acidPia Kahnberg, Andrew J Lucke, Matthew P Glenn, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
A refined agonist pharmacophore for protease activated receptor 2Grant D Barry, Jacky Y Suen, Heng Boon Low, et al.
The FEBS Journal|March 18, 2022
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and diseaseYizhuo Wang, Rishika Abrol, Jeffrey Y W Mak, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2017
Quinazolinone derivatives as inhibitors of homologous recombinase RAD51Ambber Ward, Lilong Dong, Jonathan M Harris, et al.
British Journal of Pharmacology|September 3, 2024
A novel inhibitor of class IIa histone deacetylases attenuates collagen-induced arthritisEunice K Poon, Ligong Liu, Kai-Chen Wu, et al.
Glia|September 19, 2017
Protease activated receptor 2 controls myelin development, resiliency and repairHyesook Yoon, Maja Radulovic, Grant Walters, et al.
Pageof 33